← Open Payments lookup

MARIYA GILES: Open Payments

NPI 1902156862 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,813 in 90 payments from 20 companies in 2025. Trend: 2023 $671 · 2024 $1,236 · 2025 $1,813

Food & beverage: $1,761Consulting: $52
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$281
CSL Behring15$248
Novartis Pharmaceuticals Corporation18$218
GENZYME CORPORATION7$142
Genentech USA, Inc.4$106
Takeda Pharmaceuticals U.S.A., Inc.4$105
Pharming Healthcare, Inc.3$90
GlaxoSmithKline, LLC.4$86
Regeneron Healthcare Solutions, Inc.3$79
Blueprint Medicines Corporation2$73

Products named: DUPIXENT, AYVAKIT, TEZSPIRE, Xolair, Hizentra, AIRSUPRA, Andembry, RUCONEST.

Industry payments across WA — which companies pay providers there.